Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Peanut Oral Immunotherapy With or Without H1 and...
Journal article

Peanut Oral Immunotherapy With or Without H1 and H2 Antihistamine Premedication for Peanut Allergy (PISCES): A Placebo-Controlled Randomized Clinical Trial

Abstract

BACKGROUND: Current forms of peanut oral immunotherapy (OIT) are associated with side effects, and there is a lack of evidence addressing how to mitigate them. OBJECTIVE: To determine whether premedication with desloratadine and ranitidine results in fewer side effects during peanut OIT/desensitization.

Authors

Chu DK; Freitag T; Marrin A; Walker TD; Avilla E; Freitag A; Spill P; Foster GA; Thabane L; Jordana M

Journal

The Journal of Allergy and Clinical Immunology In Practice, Vol. 10, No. 9, pp. 2386–2394

Publisher

Elsevier

Publication Date

September 2022

DOI

10.1016/j.jaip.2022.05.015

ISSN

2213-2198